Analysis of Postural Control of COPD Patients (ATTRACTION)

NCT ID: NCT05211674

Last Updated: 2022-01-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

32 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-02-28

Study Completion Date

2023-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chronic Obstructive Pulmonary Disease (COPD) is a common chronic respiratory disease, causing disabling respiratory symptoms and impairing patients' quality of life. Currently one of the leading causes of death worldwide, COPD is a major socio-economic concern. It is also accompanied by extremely frequent extra-respiratory manifestations (or co-morbidities). Among these secondary manifestations, the equilibrium of these patients is subject to modifications: thus, numerous studies have shown that the equilibrium of COPD patients was altered compared to healthy age-matched subjects. This alteration is associated with a greater functional limitation and a higher risk of falling. Although this impairment has been demonstrated clinically, the balance of these patients has never been analysed using quantified movement analysis tools during tasks similar to those performed in daily life. Moreover, the underlying mechanisms remain unknown and the possible associations with several clinical factors of interest (pain, dyspnea, muscle function...) have not yet been assessed. The hypotheses of this project are that (1) the postural control of COPD patients is altered compared to healthy subjects during tasks of daily living and these changes can be characterised. (2) Several clinical factors are associated with these changes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

COPD patients

quantified analysis of postural control during activities of daily living

Intervention Type OTHER

functional tests that reproduce tasks of daily living (timed up and go test with and without dual cognitive task, modified Glittre ADL test)

Healthy controls

quantified analysis of postural control during activities of daily living

Intervention Type OTHER

functional tests that reproduce tasks of daily living (timed up and go test with and without dual cognitive task, modified Glittre ADL test)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

quantified analysis of postural control during activities of daily living

functional tests that reproduce tasks of daily living (timed up and go test with and without dual cognitive task, modified Glittre ADL test)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* COPD patients GOLD stage 2 and 3 (A-D)
* In accordance with Article L1121-8-1 of the Public Health Code, participants must be affiliated to a social security scheme or benefit from such a scheme.

Exclusion Criteria

1. the presence of long-term or exercise-based oxygen therapy,
2. the presence of a medically diagnosed pathology causing manifest disorders of balance,
3. the inability to walk 150 m without stopping and to climb or descend stairs,
4. a history of pneumonectomy or lobectomy within the last six months,
5. the existence of an acute respiratory exacerbation within the last two months,
6. the presence of obvious cognitive impairment that impairs comprehension of instructions,
7. body mass index less than 21 or more than 35 kg/m².
8. Person referred to in articles L. 1121-5 to L. 1121-8 and L. 1121-12 of the public health code:

* Pregnant woman, woman in labour or nursing mother
* Person deprived of liberty by judicial or administrative decision
* Person hospitalised without consent and not subject to a legal protection measure, and person admitted to a health or social establishment for purposes other than research
* Minor
* Person subject to a period of exclusion for other research
* Person of full age subject to a legal protection measure (guardianship, curatorship or safeguard of justice), person of full age unable to express their consent and not subject to a protection measure
9. Person under psychiatric care
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rennes University Hospital

OTHER

Sponsor Role collaborator

University of Rennes 2

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Graziella Brinchault

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Graziella Brinchault, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital of Rennes

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Romain Pichon, MSc

Role: CONTACT

0667774267

Armel Cretual, PhD

Role: CONTACT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

M2S-ATTRACTION

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.